Eli Lilly CEO David Ricks during an interview at the Economic Club of New York (Jeenah Moon/Bloomberg via Getty Images)
March 13, 2024 10:15 AM EDTUpdated 02:28 PM
Pharma

Eli Lil­ly CEO David Ricks talks Chi­na, AI, and phar­ma's next 'gold­en er­a' af­ter obe­si­ty

Andrew Dunn

Senior Biopharma Correspondent

NEW YORK — Eli Lil­ly CEO David Ricks shared his view from the phar­ma in­dus­try’s peak in an hour­long con­ver­sa­tion Tues­day with the Eco­nom­ic Club of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times